XRTX (XORTX Therapeutics) Other Stockholders Equity : $5.61 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is XORTX Therapeutics Other Stockholders Equity?

XORTX Therapeutics's Other Stockholders Equity for the quarter that ended in Sep. 2024 was $5.61 Mil.

XORTX Therapeutics's quarterly Other Stockholders Equity increased from Mar. 2024 ($5.55 Mil) to Jun. 2024 ($5.59 Mil) and increased from Jun. 2024 ($5.59 Mil) to Sep. 2024 ($5.61 Mil).

XORTX Therapeutics's annual Other Stockholders Equity increased from Dec. 2021 ($5.02 Mil) to Dec. 2022 ($6.22 Mil) but then declined from Dec. 2022 ($6.22 Mil) to Dec. 2023 ($5.49 Mil).

XORTX Therapeutics Other Stockholders Equity Historical Data

The historical data trend for XORTX Therapeutics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XORTX Therapeutics Other Stockholders Equity Chart

XORTX Therapeutics Annual Data

Trend

Feb15

Feb16

Feb17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

0.52

0.81

5.02

6.22

5.49

XORTX Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Stockholders Equity	Get a 7-Day Free Trial															9.64	5.49	5.55	5.59	5.61

XORTX Therapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

XORTX Therapeutics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of XORTX Therapeutics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

XORTX Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XORTX Therapeutics Inc (NAS:XRTX) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ANUA:Germany XRTX:Canada

Address

3710 - 33rd Street NW, Calgary, AB, CAN, T2L 2M1

Website

https://www.xortx.com

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.